Filing Details
- Accession Number:
- 0001209191-14-003884
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-01-17 21:04:39
- Reporting Period:
- 2014-01-16
- Filing Date:
- 2014-01-17
- Accepted Time:
- 2014-01-17 21:04:39
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1142596 | Nuvasive Inc | NUVA | Surgical & Medical Instruments & Apparatus (3841) | 330768598 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1289408 | Keith Valentine | 7475 Lusk Blvd. San Diego CA 92121 | President & Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-01-16 | 20,000 | $18.31 | 64,226 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-01-16 | 20,000 | $37.96 | 44,226 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right-to-Buy) | Disposition | 2014-01-16 | 20,000 | $0.00 | 20,000 | $18.31 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
61,534 | 2010-01-03 | 2016-01-03 | No | 4 | M | Direct |
Footnotes
- The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on December 13, 2013, which is intended to comply with Rule 10b5-1.
- The shares sold were acquired contemporaneously upon the cashless exercise of a stock option at an exercise price of $18.31 per share.